Notch signaling regulates tumor-induced angiogenesis in SPARC-overexpressed neuroblastoma

Blockade of Notch Signaling in Tumor-Bearing Mice May Lead to Tumor Regression, Progression, or Metastasis, Depending on Tumor Cell Types

(2015) Xing-Bin Hu et al.   NEOPLASIA

Anti-Angiogenic Agents in Pancreatic Cancer: A Review

(2012) Murwarid M. Assifi et al.   Anti-Cancer Agents in Medicinal Chemistry

VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future

(2012) P. S. Sharma et al.   CURRENT CANCER DRUG TARGETS

SPARC Overexpression Inhibits Cell Proliferation in Neuroblastoma and Is Partly Mediated by Tumor Suppressor Protein PTEN and AKT

(2012) Praveen Bhoopathi et al.   PLoS One

MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma

(2011) Amanda Tivnan et al.   BMC CANCER

Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial–mesenchymal transition

(2011) T Li et al.   CANCER GENE THERAPY

SPARC Stimulates Neuronal Differentiation of Medulloblastoma Cells via the Notch1/STAT3 Pathway

(2011) P. Bhoopathi et al.   CANCER RESEARCH

Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer

(2011) Sònia Tugues et al.   MOLECULAR ASPECTS OF MEDICINE

Signaling Pathways Governing Tumor Angiogenesis

(2011) Toshiharu Sakurai et al.   ONCOLOGY

Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas

(2010) A. P. Bhatt et al.   BLOOD

GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer

(2010) Kristi D Lynn et al.   BMC CANCER

The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine

(2010) P Bhoopathi et al.   BRITISH JOURNAL OF CANCER

Modulating the tumor microenvironment to increase radiation responsiveness

(2010) Jayashree Karar et al.   CANCER BIOLOGY & THERAPY

Autocrine regulation of glioblastoma cell-cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay

(2010) Petra Knizetova et al.   CELL CYCLE

Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors

(2010) Alexandre Chlenski et al.   Molecular Cancer

Low Doses of Ionizing Radiation Promote Tumor Growth and Metastasis by Enhancing Angiogenesis

(2010) Inês Sofia Vala et al.   PLoS One

Tissue Inhibitor of Metalloproteinase 3 Suppresses Tumor Angiogenesis in Matrix Metalloproteinase 2-Down-regulated Lung Cancer

(2008) C. Chetty et al.   CANCER RESEARCH

Growth Inhibition and Radiosensitization of Glioblastoma and Lung Cancer Cells by Small Interfering RNA Silencing of Tumor Necrosis Factor Receptor-Associated Factor 2

(2008) M. Zheng et al.   CANCER RESEARCH

Angiogenesis as a target in neuroblastoma

(2008) Jochen Rössler et al.   EUROPEAN JOURNAL OF CANCER

The tumor microenvironment and its contribution to tumor evolution toward metastasis

(2008) Girieca Lorusso et al.   HISTOCHEMISTRY AND CELL BIOLOGY

SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion

(2008) Christopher K. Yunker et al.   INTERNATIONAL JOURNAL OF CANCER

Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells

(2008) Chandramu Chetty et al.   INTERNATIONAL JOURNAL OF CANCER

FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue

(2008) Y. Xue et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA